Zenasbio — Zenas BioPharma is a global clinical-stage biopharmaceutical company focused on developing and delivering transformative treatments for patients with autoimmune and rare diseases. Its lead candidates are obexelimab, a bifunctional monoclonal antibody that inhibits B-cell activity without depleting B cells, and orelabrutinib, an oral… - View it on GitHub